Longwood Fund
Overview
Longwood Fund is a venture capital firm dedicated to creating and investing in novel healthcare companies that develop important treatments to help patients while generating significant value for investors . The Longwood team has a long history of successfully launching and building important life science companies while providing operational leadership and strategic guidance . Collectively, the Partners at Longwood Fund have co-founded approximately 25 companies with over 20 launched or marketed drugs and therapies, as well as over two dozen clinical-stage assets, all focused on helping patients in need .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Flexiv | Dec 2020 | Series B | Co-investor |
| Avenzo Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
| Mediar Therapeutics | Jan 2026 | Series B | Co-investor |
| XyloCor Therapeutics | Mar 2021 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
John McCabe
Operating Partner
Rob Hadfield
General Counsel And Operating Partner
Annalisa D'Andrea
Venture Partner
Lea Hachigian
Venture Partner
Rich Aldrich
Venture Partner
Roger Tung
Venture Partner
Aleks Radovic-Moreno
Partner
David Donabedian
Executive Partner
Vikas Goyal
Partner, Growth Investments
Lucy Liu
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Longwood Fund based?
Longwood Fund is headquartered in Boston, Massachusetts, United States.
When was Longwood Fund founded?
Longwood Fund was founded in 2010.
How many portfolio companies does Longwood Fund have?
Longwood Fund has 33 portfolio companies in Caplight's dataset.
What are some companies in Longwood Fund's portfolio?
Portfolio companies visible on Caplight include Flexiv, Avenzo Therapeutics, Crystalys Therapeutics, Mediar Therapeutics, XyloCor Therapeutics.
What was Longwood Fund's most recent investment shown here?
Longwood Fund's most recent investment in this portfolio sample was in Crystalys Therapeutics in 2026.
What sectors does Longwood Fund focus on?
Longwood Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Healthcare & Life Sciences, Real Estate & PropTech, AI, Data & Cloud Infrastructure.
What company stages does Longwood Fund focus on?
Longwood Fund typically invests at the MultiStage stage.
What is Longwood Fund's AUM?
Longwood Fund's assets under management are estimated between $500.0M and $1.0B.